Little Italy in Downtown San Diego has been selected as the location for the first biotech firm relocating to the area. Dublin, Ireland-based medical firm Mainstay Medical is relocating their headquarters to 2171 India St. in a project that will consist of office space, retail, and even dining. The firm is planning on utilizing the space for both office functions and light manufacturing.
Recognized as a landmark deal for downtown San Diego, investors are ecstatic to see the potential of their investments starting to pay off. Many real-estate investors have been banking on the downtown area to become the new home to life sciences. The area is perfect, especially with its proximity to the bay. Mainstay Medical chose the location for its “European and urban feel.”
Many life science students have already begun searching for downtown San Diego condos and other places to live. In fact, investors predict that Mainstay Medical is only the first of many biotech firms that will be attracted to Little Italy and downtown for all it has to offer. Apartment complexes and offices spaces have sprouted around the area with the expectation that the life science sector will take over the area.
Development, of course, has been stalled due to the COVID-19 pandemic. San Diego Mayor Todd Gloria predicted that the population will double in size over the course of the next two decades. While the pandemic may have slowed the process, investors and developers are taking advantage and charging full-speed ahead with their proposed plans.
Mainstay Medical is a medical device company founded in 2008 that specializes in a neurostimulation system that treats people with disabling chronic lower back pain. They announced that they will be launching their system in the United States by the end of the summer. As their business grows internationally, job seekers in the biotech industry in the US may find their way to downtown San Diego’s Mainstay Medical headquarters.